cisatracurium

(redirected from Cisatracurium besylate)

cisatracurium

[sis″at-rah-kūr´e-um]

a nondepolarizing neuromuscular blocking agent administered intravenously as the besylate salt administered intravenously to facilitate endotracheal intubation and to induce skeletal muscle relaxation, either as an adjunct to general anesthesia during surgery or during mechanical ventilation.

cisatracurium

Anesthesiology A stereoisomer of atracurium, a nondepolarizing muscle relaxing anesthetic preferred in multiorgan failure. See Muscle relaxant, Nondepolarizing agent. Cf Depolarizing agent.

References in periodicals archive ?

Nebraska is currently planning to execute inmates with a never-before-tried mix of four drugs: diazepam (more commonly known as Valium), potassium chloride, cisatracurium besylate (a paralytic), and fentanyl citrate.

AMERICA'S SECRET DEATH PENALTY DRUGS

Following adequate preoxygenation using 100% oxygen via a face mask for 3 min, general anesthesia was administered via an intravenous injection of 2 mg midazolam, 1–2 mg/kg propofol, 0.4–0.6 [micro]g/kg sufentanil, and neuromuscular blockade with 0.2 mg/kg cisatracurium besylate. After confirming ease of mask ventilation, the patients' heads and necks were maintained in the neutral or relatively extended position supported by a pillow.

Evaluation of Endotracheal Intubation with a Flexible Fiberoptic Bronchoscope in Lateral Patient Positioning: A Prospective Randomized Controlled Trial

Fresenius Kabi, a Germany-based health care company, has introduced its Cisatracurium Besylate Injection, a new specialty injectable product, in three presentations in the United States, it was reported yesterday.

Cisatracurium Besylate Injection launched in US by Fresenius Kabi

In the neurological population it is most often used for patients placed on a neuromuscular blockade drip such as cisatracurium besylate (Nimbex), which is accompanied by sedation such as propofol (Diprivan), and for patients placed in a pentobarbital-induced coma.